Stockholm Pilot Tests Compassion-Focused Group Therapy for Stubborn Depression and Anxiety
A small psychiatric outpatient study in Stockholm has put compassion-focused group therapy through a practical test in adults whose depression and anxiety persisted after prior treatment. The pilot was designed less as a proof-of-efficacy trial than as a feasibility check: could a manualized 11-week group intervention be delivered in routine care, and would people with ongoing self-criticism and shame stay engaged long enough for it to matter clinically?
The answer to the first question was the real business of the study. In a specialty outpatient clinic at Sollentuna Psychiatric Outpatient Clinic, Psychiatry Northwest, investigators enrolled 21 adults between 2023 and 2024 and delivered the program in three treatment groups. The study completed on April 8, 2024, after beginning on July 1, 2023.
Why Self-Criticism Became the Therapeutic Target
Depression and anxiety rarely present as pure symptom clusters in specialty psychiatric care. Many patients arrive with a longer emotional history: repeated treatment attempts, lingering shame, harsh self-judgment, and a felt inability to respond to distress without turning the criticism inward. Compassion-focused therapy is built around that pattern. Its central premise is straightforward: when self-attack and shame keep the threat system switched on, psychological distress becomes harder to regulate and harder to recover from.
The intervention was tailored to that clinical logic. Participants had to be adults with moderate to severe symptoms of depression and/or anxiety, and they had to have already completed at least one pharmacological or psychological treatment consistent with Swedish national guidelines. They also had to report difficulties tied to self-criticism or shame during the initial assessment. In other words, this was not a first-line sample. It was a treatment-resistant or treatment-refractory outpatient population in which standard approaches had not fully resolved the emotional drivers of illness.
Exclusion criteria were equally pragmatic. Patients unable to complete self-report questionnaires independently, those with practical barriers that made group attendance unrealistic, and anyone with an acute physical or psychiatric condition requiring immediate hospital care were not eligible. Severe underweight and an acute suicidal crisis were among the examples listed.
An 11-Week Group Model Built for Routine Care
The intervention itself was manualized and structured. Participants attended weekly group sessions lasting about 2 hours and 15 minutes, paired with brief individual telephone consultations of approximately 15 minutes each week. The treatment package included psychoeducation, experiential exercises, meditation, compassion-focused practices, and individual case conceptualization. Additional individual appointments were offered before treatment, midway through the program, and again at the three-month follow-up.
That design matters because it reflects the practical demands of psychiatric outpatient work. Group treatment can expand access, but it also exposes the brittle points of real-world care: scheduling conflicts, variable attendance, uneven symptom burden, and the challenge of keeping patients engaged when motivation is low. A one-on-one psychotherapy model may be easier to individualize, but group delivery can be more scalable if patients can tolerate and value the format.
The study enrolled 21 participants and assigned them to three treatment groups. It used an open-label, single-arm design with no randomization and no control group. For this reason, the study was not built to settle the question of efficacy. It was built to determine whether the intervention could be delivered, completed, and tolerated in a specialized psychiatric outpatient setting.
Feasibility Was the Primary Endpoint, Not Symptom Relief
The primary outcome was the treatment completion rate, a direct measure of feasibility. Researchers also tracked recruitment, initiation, retention, attendance at group sessions, and participation in scheduled telephone consultations. In a pilot like this, those operational details are not administrative footnotes; they are the outcome. A psychotherapy can be conceptually elegant and still fail if patients cannot attend, do not complete the program, or find the format unacceptable in practice.
This study also looked at a broad set of clinical measures before treatment, immediately after treatment, and three months later. The primary clinical symptom target was self-compassion, measured with the Self-Compassion Scale-Short Form. Secondary outcomes included depressive symptoms on the Patient Health Questionnaire-9, difficulties in emotion regulation on the DERS-16, social safeness on the Social Safeness and Pleasure Scale, functional impairment on the WHODAS-12, and quality of life on the Brunnsviken Brief Quality of Life Scale.
Those measures fit the therapeutic model. If compassion-focused therapy is doing what it is meant to do, self-compassion should rise first, followed by less emotional reactivity, less social threat perception, and eventual improvement in functioning and quality of life. The sequence is clinically plausible because shame and self-criticism can act as chronic internal stressors, keeping patients locked into avoidance and defensive patterns long after the original depressive or anxious episode has stabilized.
One sentence captures the central limitation of the evidence here: no comparative efficacy claim can be made from a single-arm pilot.
What the Study Can and Cannot Tell Clinicians
The record does not include posted results, so the study should be read as a feasibility signal rather than a treatment endorsement. Even so, the design gives clinicians a useful glimpse into how compassion-focused therapy is being operationalized in specialty care. The population was clearly defined, the intervention was manualized, the delivery was structured, and the follow-up window extended to three months after treatment.
The study also signals a shift in how outpatient psychiatry may think about persistent depression and anxiety. In patients whose symptoms remain partly anchored by shame, self-criticism, and difficulty with self-soothing, a therapy centered on compassion may address a mechanism that conventional symptom-focused care does not always reach. Group format could make that approach more accessible, but only if patients can actually stay in treatment long enough to benefit.
Enrollment totaled 21 adults, all 18 years or older, and the study accepted no healthy volunteers. The trial was classified as interventional, phase not applicable, with a primary purpose of treatment. It carried the official title Investigation of Loneliness and Its Associations With Emotion Regulation, Lifestyle Habits, Mental Health Problems, and Psychotherapeutic Treatment Outcomes, Substudy 5: Compassion-Focused Therapy (CFT) for Depression and Anxiety Disorders.
The most concrete takeaway is narrow but clinically relevant: this Stockholm pilot was designed to test whether compassion-focused psychotherapy can be integrated into routine psychiatric outpatient care for adults whose depression or anxiety has persisted despite prior guideline-based treatment. The unanswered clinical question is not whether compassion matters as a concept. It is whether a structured group intervention can reliably change the self-critical patterning that keeps these patients symptomatic, and whether those changes will hold beyond a short follow-up window.